Vernalis PLC Share News (VER)

Vernalis Buys Rights To MOXATAG Amoxicillin Antibiotic

Vernalis Says Has Cash To Reach Profitability As Focuses On Tuzistra

Earnings, Trading Statements Calendar - Week Ahead

Vernalis Launches Cough & Cold Treatment Tuzistra XR In US

Vernalis slumps after disappointing Phase II results

(ShareCast News) - Vernalis said results of the phase II proof-of-concept study of its fatty acid amide hydrolase inhibitor, which is being investigated as a treatment for neuropathic pain, failed to meet its pain-reduction primary endpoint. The biopharmaceutical research and development company sai

Vernalis Says Product Fails To Meet Pain Reduction Primary Endpoint

FTSE 250 movers: Miners drag index down, Synthomer spikes higher

(ShareCast News) - The FTSE 250 index was by late on Tuesday afternoon giving up some of the gains made late the day before, as commodities-focused stocks were hit by China's devaluation and corporate news received mixed reviews. By 1540 BST the index was down 0.47% at 17,677.29 points, with Vedanta

Vernalis Says Stability Testing Of 2nd Cough-Cold Product Has Begun

DIRECTOR DEALINGS SUMMARY: Outgoing Whitbread CEO Halves Shareholding

DIRECTOR DEALINGS: Vernalis Non-Executive Director Buys Shares

BUZZ-Vernalis: Tuzistra XR green light hoists stock to 5-yr high

** Pharma co Vernalis up c.15 pct at 5-yr high & on track for biggest one-day rise since Aug 2014 ** FDA approves co's first cough/cold medicine Tuzistra XR ** News sparks target price hikes from Stifel (74p vs 63p), Peel Hunt (68p vs 62p) & Canaccord Genuity (92p vs 66p) ** Sha

Vernalis Says US Regulator Approves New Drug Application For Tuzistra

Vernalis In Drug Discovery Collaboration With Japan's Taisho

Vernalis Gets GBP500,000 Milestone Payment From Asahi Collaboration

Vernalis Enters Licence Deal With US-Based Biotechnology Firm